Biomaterials, 2009 · DOI: 10.1016/j.biomaterials.2008.12.051 · Published: April 1, 2009
The study explores delivering genes to injured spinal cords using tissue engineering scaffolds. These scaffolds, coated with extracellular matrix (ECM) and DNA, aim to promote tissue regeneration by directing cell function and influencing cellular responses through localized production of tissue inductive factors. The method involves surface immobilization of DNA complexed with lipids (lipoplexes) onto the scaffold. This approach can be applied to scaffolds with complex geometries and allows for precise control over where the DNA is placed, potentially creating gradients of inductive factors. The spinal cord bridges contain multiple linear guidance channels to support cell infiltration and integrate into the spinal cord, while the channels induced cell orientation along its major axis and supported and directed axons elongation across the channels.
The combination of tissue engineering and gene therapy shows promise for spinal cord regeneration by delivering genes that can address multiple barriers to recovery, such as cell survival and axonal elongation.
Surface-mediated delivery of lipoplexes from fibronectin-coated bridges offers an efficient DNA delivery system after spinal cord injury, requiring only small amounts of DNA to induce transgene expression for an extended period.
The study highlights the importance of scaffold surface properties, particularly the use of fibronectin coating, in maximizing gene transfer and promoting tissue regeneration.